Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
The Patients Before Monopolies Act was introduced into both the U.S. Senate and House of Representatives with bipartisan support. If it passes, pharmacy benefit managers would be required to divest from retail stores.
The Centers for Medicare & Medicaid Services said it’s issuing a nationwide moratorium on new providers entering the spaces until it has a chance to look into allegations of fraud, waste and abuse. It confirmed investigations of various organizations are pending.
Despite newly implemented tariffs, the manufacturer says it was profitable in Q1 of 2025, but a greater impact on its operations looms later this year.
Healthcare may finally have struck a healthy balance between AI hype and AI reality, according to a report from impartial observers who are also, indirectly at least, healthcare AI stakeholders.
The Massachusetts senator is asking buyer Sycamore Partners for certain assurances, including that it won’t saddle the struggling pharmacy chain with even more debt and indiscriminately close retail locations.
Ontario-based Andlauer Healthcare Group ships sensitive temperature-controlled products necessary for healthcare manufacturing and research. It has agreed to be acquired by the world’s largest courier, with the all-cash deal expected to close later this year.
The pharmacy chain was accused of filling “millions” of unlawful prescriptions for opioids and other controlled substances. Despite agreeing to the payout, the company does not admit wrongdoing.